These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 22505526)

  • 1. Assay-dependent abnormalities in measurements of prostate-specific antigen in serum: an occasional occurrence, but of clinical significance.
    Jung K; Stephan C; Lein M
    Clin Chem Lab Med; 2011 Dec; 50(3):585-6. PubMed ID: 22505526
    [No Abstract]   [Full Text] [Related]  

  • 2. Aberrant results observed with four immuno-assays for total and free prostate-specific antigen (PSA) determination: a case-report.
    Cavalier E
    Clin Chem Lab Med; 2011 Nov; 50(3):583-4. PubMed ID: 22112055
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostate specific antigen: biology, biochemistry and available commercial assays.
    Ward AM; Catto JW; Hamdy FC
    Ann Clin Biochem; 2001 Nov; 38(Pt 6):633-51. PubMed ID: 11732646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sensitive assay to measure biomarker glycosylation demonstrates increased fucosylation of prostate specific antigen (PSA) in patients with prostate cancer compared with benign prostatic hyperplasia.
    Dwek MV; Jenks A; Leathem AJ
    Clin Chim Acta; 2010 Dec; 411(23-24):1935-9. PubMed ID: 20708609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct electronic detection of prostate-specific antigen in serum.
    Briman M; Artukovic E; Zhang L; Chia D; Goodglick L; Gruner G
    Small; 2007 May; 3(5):758-62. PubMed ID: 17352433
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum-based ALYGNSA immunoassay for the prostate cancer biomarker, total prostate-specific antigen (tPSA).
    Mackness BC; McDonald MJ
    Anal Bioanal Chem; 2010 Aug; 397(7):3151-4. PubMed ID: 20556365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Elecsys® Vitamin B12 assay is not affected by anti-intrinsic factor antibodies.
    Schilling KA; Wiesgigl M
    Clin Chem Lab Med; 2013 Jun; 51(11):e251-2. PubMed ID: 23813358
    [No Abstract]   [Full Text] [Related]  

  • 8. Integrated microfluidic systems with an immunosensor modified with carbon nanotubes for detection of prostate specific antigen (PSA) in human serum samples.
    Panini NV; Messina GA; Salinas E; Fernández H; Raba J
    Biosens Bioelectron; 2008 Feb; 23(7):1145-51. PubMed ID: 18162392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different stability of free and complexed prostate-specific antigen in serum in relation to specimen handling and storage conditions.
    Jung K; Lein M; Brux B; Sinha P; Schnorr D; Loening SA
    Clin Chem Lab Med; 2000 Dec; 38(12):1271-5. PubMed ID: 11205692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-specific antigen immunosensing based on mixed self-assembled monolayers, camel antibodies and colloidal gold enhanced sandwich assays.
    Huang L; Reekmans G; Saerens D; Friedt JM; Frederix F; Francis L; Muyldermans S; Campitelli A; Van Hoof C
    Biosens Bioelectron; 2005 Sep; 21(3):483-90. PubMed ID: 16076438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between equimolar- and skewed-response assays of prostate specific antigen: is there an influence on the clinical significance when measuring total serum prostate specific antigen?
    Jung K; Lein M; Schnorr D; Brux B; Henke W; Loening S
    Ann Clin Biochem; 1996 May; 33 ( Pt 3)():209-14. PubMed ID: 8791983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-step homogeneous magnetic nanoparticle immunoassay for biomarker detection directly in blood plasma.
    Ranzoni A; Sabatte G; van Ijzendoorn LJ; Prins MW
    ACS Nano; 2012 Apr; 6(4):3134-41. PubMed ID: 22414272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of prostate-specific antigen in serum using four different immunoassays.
    Cattini R; Robinson D; Gill O; Jolley N; Bacarese-Hamilton T
    Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):181-5. PubMed ID: 7518258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biases in antibody-based single-phase assays for free thyroxine due to protein-bound analyte.
    Tanhehco YC; Peck Palmer OM; Derrico LS; Sepulveda JL; Blair HC
    Clin Chim Acta; 2009 Aug; 406(1-2):176-8. PubMed ID: 19500559
    [No Abstract]   [Full Text] [Related]  

  • 15. Multicenter Comparison of Four Automated Immunoassay Analyzers for Prostate Specific Antigen.
    Park DJ; Kim Y; Lee HK; Lee J; Han K; Kwon HJ
    Ann Lab Med; 2019 Jul; 39(4):406-410. PubMed ID: 30809989
    [No Abstract]   [Full Text] [Related]  

  • 16. Investigation of human anti-mouse antibodies as potential cause of postprostatectomy PSA elevation.
    Loeb S; Schaeffer EM; Chan DW; Carter HB; Walsh PC; Sokoll LJ
    Urology; 2009 May; 73(5):947-9. PubMed ID: 19394489
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantum-dot-basedFörster resonance energy transfer immunoassay for sensitive clinical diagnostics of low-volume serum samples.
    Wegner KD; Jin Z; Lindén S; Jennings TL; Hildebrandt N
    ACS Nano; 2013 Aug; 7(8):7411-9. PubMed ID: 23909574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of thyroglobulin antibody interference in first- and second-generation thyroglobulin immunoassays.
    Giovanella L; Ceriani L
    Clin Chem Lab Med; 2011 Jun; 49(6):1025-7. PubMed ID: 21391869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface plasmon fluorescence immunoassay of free prostate-specific antigen in human plasma at the femtomolar level.
    Yu F; Persson B; Löfås S; Knoll W
    Anal Chem; 2004 Nov; 76(22):6765-70. PubMed ID: 15538801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantum-dot-based electrochemical immunoassay for high-throughput screening of the prostate-specific antigen.
    Wang J; Liu G; Wu H; Lin Y
    Small; 2008 Jan; 4(1):82-6. PubMed ID: 18081131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.